Mitomycin C in the treatment of pterygium

Clinical and Experimental Ophthalmology

Volumn 34, Issue 3, 2006, Pages 197-198

  Hirst, Lawrence W ^a  

^a QUEENSLAND EYE INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

AUSTRALIA; BLINDNESS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG EXPOSURE; EDITORIAL; ELECTRON THERAPY; HEALTH CARE COST; HUMAN; MEDICARE; OPERATION DURATION; PLASTIC SURGERY; PTERYGIUM; RECURRENCE RISK; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

ANTIBIOTICS, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; CONJUNCTIVA; HUMANS; MITOMYCIN; PTERYGIUM; SURGICAL FLAPS;

EID: 33645754454     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2006.01195.x     Document Type: Editorial

References (15)

1. Wlodarczyk J, Whyte P, Cockrum P, Taylor H. Pterygium in Australia: A cost of illness study. Clin Experiment Ophthalmol 2001; 29: 370-5.
2. Hirst LW. The treatment of pterygium. Surv Ophthalmol 2003; 48: 145-80.
3. Sebban A, Hirst LW. Treatment of pterygia in Queensland. Aust NZ J Ophthalmol 1990; 19: 123-7.
4. MacKenzie F, Hirst LW, Kynaston B. Recurrence rate and complications after beta irradiation for pterygia. Ophthalmology 1991; 98: 1776-80.
5. Troutbeck R, Hirst L. Review of treatment of pterygium in Queensland: 10 years after a primary survey. Clin Experiment Ophthalmol 2001; 29: 286-90.
6. Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea 1996; 15: 537-40.
7. Hayasaka S, Iwasa Y, Nagaki Y, Kadoi C, Matsumoto M, Hayasaka Y. Late complications after pterygium excision with high dose mitomycin C instillation. Br J Ophthalmol 2000; 84: 1081-2.
8. Safianik B, Ben-Zion I, Garzozi HJ. Serious corneoscleral complications after pterygium excision with mitomycin C. Br J Ophthalmol 2002; 86: 357-8.
9. Rubinfeld RS, Pfister RR, Stein RM et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992; 99: 1647-54.
10. Yamanouchi U, Mishima K. Eye lesions due to mitomycin C instillation after pterygium operation. Nippon Ganka Kiyo 1967; 18: 854-61.
11. Chen PP, Ariyasu RG, Kaza V, LaBree LD, McDonnell PJ. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. Am J Ophthalmol 1995; 120: 151-60.
12. Panda A, Das GK, Tuli SW, Kumar A. Randomized trial of intraoperative mitomycin C in surgery for pterygium. Am J Ophthalmol 1998; 125: 59-63.
13. Young AL, Leung GYS, Wong AKK, Cheng LL, Lam DSC. A randomised trial comparing 0.02% mitomycin C and limbal conjunctival autograft after excision of primary pterygium. Br J Ophthalmol 2004; 88: 995-7.
14. Anduze AL. Pterygium surgery with mitomycin-C: Ten-year results. Ophthalmic Surg Lasers 2001; 32: 341-5.
15. Uçakhan ÖÖ, Kanpolat A. Combined 'symmetrical conjunctival flap transposition' and intraoperative low-dose mitomycin C in the treatment of primary pterygium. Clin Experiment Ophthalmol 2006; 34: 219-25.